SIS Ventures is launching a second round of fundraising to attract up to £3.7 million to scale up its support for high impact enterprises.
The Impact First Fund previously raised £1.3 million from 25 UK-based private investors. More than 100 high-growth early-stage enterprises, focused on delivering profit with purpose, have applied for funding, with eight having secured or in active discussion about investment.
TalkingMedicines, the Glasgow headquartered data-tech company whose data products allow pharmaceutical companies to make patient centric marketing decisions, driving more effective medicines.
EnteroBiotix , the Aberdeen-headquartered life sciences firm which harnesses bacteria from the human gut to prevent and treat infections and diseases.
Brewgooder, the Edinburgh craft beer label on a mission to bring clean water to one million people.
Cyan Forensics, the Edinburgh-based Napier University spin-out whose technology lets law enforcement, social media, and cloud companies detect, block and restrict distribution of harmful digital content to protect vulnerable groups.
Good-Loop , the video, social and rich media solution, connecting viewers and brands through ethical, high quality formats – all while giving 50% of revenues to charities.
The second round of fundraising will showcase the success of these first investments as proof of the Fund’s purpose-led investment.
SIS Ventures is the investment arm of responsible finance provider Social Investment Scotland (SIS). In December it appointed David Ovens, Chief Operating Officer at Archangels and former Vice Chair of SIS Ventures, as chair of SIS Ventures to support the next phase of growth.
Alastair Davis, CEO, SIS Ventures, said: “Demand for investment funding from early stage mission-led entrepreneurs has surpassed all of our expectations. Since launching Impact First last year, we have proved without doubt that there is more than sufficient appetite for such a Fund among highly ambitious enterprises with aspirations for growth.
“We also know from our ongoing discussions with the investor community that investor interest is strong. However, to date, many have adopted a ‘wait and see’ approach, based on the relative scarcity of evidence to support an impact-first investment approach.
“With our first portfolio of investments almost complete, we are now able to more visibly prove the investment case. We’ve already started our discussions with the investor community, and we’ll be looking to complete the second raise within a few months.”